Substance Abuse Treatment Prevention and Policy
ISSN 1747-597x · BioMed Central · United Kingdom · active 2006–2026
Metrics
- Best Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 2.8
- SJR
- 1.009
- h-index
- 80
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 25 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Substance Abuse Treatment Prevention and Policy is Q1 in 1 of its 2 subject categories and Q2 in the other 1. Its best category quartile is Q1.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Health Policy | Q1 | #69 of 334 |
| Psychiatry and Mental Health | Q2 | #173 of 605 |
- Cites per document (2 years, Scopus)
- 3.29
- Documents indexed in 2025 (Scopus)
- 54
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Substance Abuse Treatment Prevention and Policy is Q1 in 1 of its 2 Scimago subject categories (2025 edition; best category Health Policy: Q1, #69 of 334), with SJR 1.009 (Scimago) and an h-index of 80 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to first decision
- 42 days (median)Publisher-reported
- Submission to publication
- ~19 wkDOAJ self-reported
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- DOAJScopusWeb of SciencePubMed
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Substance Abuse Treatment Prevention and Policy a predatory journal?
Our screening does not flag Substance Abuse Treatment Prevention and Policy. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Substance Abuse Treatment Prevention and Policy indexed in Scopus or Web of Science?
Per our venue index, Substance Abuse Treatment Prevention and Policy appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Substance Abuse Treatment Prevention and Policy?
Papers in Substance Abuse Treatment Prevention and Policy are cited about 2.8 times each within two years of publication, and Scimago places it in Q1, with an h-index of 80. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Substance Abuse Treatment Prevention and Policy (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Substance Abuse Treatment Prevention and Policy is Q1 in 1 of its 2 subject categories and Q2 in the other 1. By category: Health Policy: Q1, #69 of 334; Psychiatry and Mental Health: Q2, #173 of 605. Its best category quartile is Q1. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Substance Abuse Treatment Prevention and Policy is cited about 2.8 times per paper over two years, with an h-index of 80.
What is the Web of Science (JCR) quartile of Substance Abuse Treatment Prevention and Policy?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Substance Abuse Treatment Prevention and Policy. The open equivalent is its best Scimago quartile, Q1 in Health Policy, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Substance Abuse Treatment Prevention and Policy open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
How long does Substance Abuse Treatment Prevention and Policy take to publish a paper?
Submission to first decision for Substance Abuse Treatment Prevention and Policy takes about 42 days (median) — Publisher-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Substance Abuse Treatment Prevention and Policy.
Ready to submit? Tools for your next paper
Similar venues
- Current Infectious Disease ReportsQ2 · Springer Science+Business Media
- The American Journal of Drug and Alcohol AbuseQ1 · Taylor & Francis
- Infectious DiseasesQ2 · Informa
- Journal of Lower Genital Tract DiseaseQ2 · Lippincott Williams & Wilkins
- Journal of Viral HepatitisQ2 · Wiley
- Journal of the Pediatric Infectious Diseases SocietyQ1 · Oxford University Press
Compare it with its peers: Ranked Epidemiology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.